Skip Nav Destination
Issues
Clinical Care/Education/Nutrition
Beneficial Effects of Insulin Versus Sulphonylurea on Insulin Secretion and Metabolic Control in Recently Diagnosed Type 2 Diabetic Patients
Michael Alvarsson, MD, PHD; Göran Sundkvist, MD, PHD; Ibe Lager, MD, PHD; Marianne Henricsson, MD, PHD; Kerstin Berntorp, MD, PHD; Eva Fernqvist-Forbes, MD, PHD; Lars Steen, MD; Gunilla Westermark, MD, PHD; Per Westermark, MD, PHD; Thomas Örn, MD; Valdemar Grill, MD, PHD
Diabetes Care August 2003, Vol.26, 2231-2237. doi:https://doi.org/10.2337/diacare.26.8.2231
Insulin 70/30 Mix Plus Metformin Versus Triple Oral Therapy in the Treatment of Type 2 Diabetes After Failure of Two Oral Drugs: Efficacy, safety, and cost analysis
Sherwyn Schwartz, MD; Richard Sievers, DO; Poul Strange, MD, PHD; William H. Lyness, PHD; Priscilla Hollander, MD; For The INS-2061 Study Team
Diabetes Care August 2003, Vol.26, 2238-2243. doi:https://doi.org/10.2337/diacare.26.8.2238
Adiponectin Is Present in Cord Blood but Is Unrelated to Birth Weight
Robert S. Lindsay, MB, PHD; James D. Walker, MD; Peter J. Havel, PHD; Barbara A. Hamilton; Andrew A. Calder, MD, FRCOG; Frank D. Johnstone, MD, FRCOG; on behalf of The Scottish Multicentre Study of Diabetes in Pregnancy
Diabetes Care August 2003, Vol.26, 2244-2249. doi:https://doi.org/10.2337/diacare.26.8.2244
Specialist Nurse-Led Intervention to Treat and Control Hypertension and Hyperlipidemia in Diabetes (SPLINT): A randomized controlled trial
John P. New, FRCP; James M. Mason, PHD; Nick Freemantle, PHD; Sue Teasdale, MA; Louise M. Wong, BSC; Nick J. Bruce, MSC; John A. Burns, BSC; John M. Gibson, PHD
Diabetes Care August 2003, Vol.26, 2250-2255. doi:https://doi.org/10.2337/diacare.26.8.2250
Management of Uncontrolled Hypertension in a Nurse-Led Clinic Compared With Conventional Care for Patients with Type 2 Diabetes
Elizabeth A. Denver, RN; Maria Barnard, BSC, MBCHB, FRCP; Robin G. Woolfson, MD, FRCP; Kenneth A. Earle, MD, FRCP
Diabetes Care August 2003, Vol.26, 2256-2260. doi:https://doi.org/10.2337/diacare.26.8.2256
Low–Glycemic Index Diets in the Management of Diabetes: A meta-analysis of randomized controlled trials
Diabetes Care August 2003, Vol.26, 2261-2267. doi:https://doi.org/10.2337/diacare.26.8.2261
Epidemiology/Health Services/Psychosocial Research
Impact of Population Management With Direct Physician Feedback on Care of Patients With Type 2 Diabetes
Richard W. Grant, MD, MPH; Hope E. Hamrick; Christine M. Sullivan, RN-C FNP; Anil K. Dubey, MD; Henry C. Chueh, MD; Enrico Cagliero, MD; James B. Meigs, MD, MPH
Diabetes Care August 2003, Vol.26, 2275-2280. doi:https://doi.org/10.2337/diacare.26.8.2275
Effect of Nurse-Directed Diabetes Care in a Minority Population
Diabetes Care August 2003, Vol.26, 2281-2287. doi:https://doi.org/10.2337/diacare.26.8.2281
Biologic and Quality-of-Life Outcomes From the Mediterranean Lifestyle Program: A randomized clinical trial
Deborah J. Toobert, PHD; Russell E. Glasgow, PHD; Lisa A. Strycker, MA; Manuel Barrera, Jr., PHD; Janice L. Radcliffe, PHD; Rosemary C. Wander, PHD; John D. Bagdade, MD
Diabetes Care August 2003, Vol.26, 2288-2293. doi:https://doi.org/10.2337/diacare.26.8.2288
Out-of-Pocket Costs and Diabetes Preventive Services: The Translating Research Into Action for Diabetes (TRIAD) study
Andrew J. Karter, PHD; Mark R. Stevens, MSPH, MA; William H. Herman, MD, MPH; Susan Ettner, PHD; David G. Marrero, PHD; Monika M. Safford, MD; Michael M. Engelgau, MD, MS; J. David Curb, MD, MPH; Arleen F. Brown, MD, PHD; The TRIAD Study Group
Diabetes Care August 2003, Vol.26, 2294-2299. doi:https://doi.org/10.2337/diacare.26.8.2294
The Direct Medical Cost of Type 2 Diabetes
Michael Brandle, MD; Honghong Zhou, MS; Barbara R.K. Smith, MHSA; Deanna Marriott, MAS; Ray Burke, MA; Bahman P. Tabaei, MPH; Morton B. Brown, PHD; William H. Herman, MD, MPH
Diabetes Care August 2003, Vol.26, 2300-2304. doi:https://doi.org/10.2337/diacare.26.8.2300
Predicted Costs and Outcomes From Reduced Vibration Detection in People With Diabetes in the U.S.
Diabetes Care August 2003, Vol.26, 2305-2310. doi:https://doi.org/10.2337/diacare.26.8.2305
A Descriptive and Comparative Study of the Prevalence of Depressive and Anxiety Disorders in Low-Income Adults With Type 2 Diabetes and Other Chronic Illnesses
Diabetes Care August 2003, Vol.26, 2311-2317. doi:https://doi.org/10.2337/diacare.26.8.2311
Impaired Fasting Glucose and Impaired Glucose Tolerance in Women With Prior Gestational Diabetes Are Associated With a Different Cardiovascular Profile
Luis Felipe Pallardo, MD; Lucrecia Herranz, MD; Pilar Martin-Vaquero, BM; Teresa Garcia-Ingelmo, MD; Cristina Grande, SCD; Mercedes Jañez, BM
Diabetes Care August 2003, Vol.26, 2318-2322. doi:https://doi.org/10.2337/diacare.26.8.2318
C-Reactive Protein Predicts the Deterioration of Glycemia in Chinese Subjects With Impaired Glucose Tolerance
Kathryn C.B. Tan, MD; Nelson M.S. Wat, MBBS; Sidney C.F. Tam, MD; Edward D. Janus, PHD; T.H. Lam, MD; Karen S.L. Lam, MD
Diabetes Care August 2003, Vol.26, 2323-2328. doi:https://doi.org/10.2337/diacare.26.8.2323
Diabetes and Driving Mishaps: Frequency and correlations from a multinational survey
Daniel J. Cox, PHD; Jennifer Kim Penberthy, PHD; John Zrebiec, MSW; Katie Weinger, PHD; James E. Aikens, PHD; Brian Frier, MD; Barbara Stetson, PHD; Mary DeGroot, PHD; Paula Trief, PHD; Hartmut Schaechinger, MD; Norbert Hermanns, PHD; Linda Gonder-Frederick, PHD; William Clarke, MD
Diabetes Care August 2003, Vol.26, 2329-2334. doi:https://doi.org/10.2337/diacare.26.8.2329
Prevalences of Diabetes and Impaired Glucose Regulation in a Danish Population: The Inter99 study
Diabetes Care August 2003, Vol.26, 2335-2340. doi:https://doi.org/10.2337/diacare.26.8.2335
Increased Visceral Fat and Serum Levels of Triglyceride Are Associated With Insulin Resistance in Japanese Metabolically Obese, Normal Weight Subjects With Normal Glucose Tolerance
Akira Katsuki, MD; Yasuhiro Sumida, MD; Hideki Urakawa, MD; Esteban C. Gabazza, MD; Shuichi Murashima, MD; Noriko Maruyama, MD; Kohei Morioka, MD; Kaname Nakatani, MD; Yutaka Yano, MD; Yukihiko Adachi, MD
Diabetes Care August 2003, Vol.26, 2341-2344. doi:https://doi.org/10.2337/diacare.26.8.2341
Fulminant Type 1 Diabetes: A nationwide survey in Japan
Akihisa Imagawa, MD; Toshiaki Hanafusa, MD; Yasuko Uchigata, MD; Azuma Kanatsuka, MD; Eiji Kawasaki, MD; Tetsuro Kobayashi, MD; Akira Shimada, MD; Ikki Shimizu, MD; Tetsuya Toyoda, MD; Taro Maruyama, MD; Hideichi Makino, MD
Diabetes Care August 2003, Vol.26, 2345-2352. doi:https://doi.org/10.2337/diacare.26.8.2345
Low Incidence of End-Stage Renal Disease and Chronic Renal Failure in Type 2 Diabetes: A 10-year prospective study
Graziella Bruno, MD; Annibale Biggeri, MD; Franco Merletti, MD; Giuseppe Bargero, MD; Stefania Ferrero, MD; Gianfranco Pagano, MD; Paolo Cavallo Perin, MD
Diabetes Care August 2003, Vol.26, 2353-2358. doi:https://doi.org/10.2337/diacare.26.8.2353
A Comparison of Postprandial and Preprandial Administration of Insulin Aspart in Children and Adolescents With Type 1 Diabetes
Thomas Danne, MD; Jan Aman, MD; Edith Schober, MD; Dorothee Deiss, MD; Judith L. Jacobsen, MSC; Hans Henrik Friberg, MSC; Lars Hein Jensen, MSC PHARM; the ANA 1200 Study Group
Diabetes Care August 2003, Vol.26, 2359-2364. doi:https://doi.org/10.2337/diacare.26.8.2359
Does Low Bone Mineral Density Start in Post-Teenage Years in Women With Type 1 Diabetes?
Emily Y. Liu, MD; Jean Wactawski-Wende, PHD; Richard P. Donahue, PHD; Jacek Dmochowski, PHD; Kathleen M. Hovey, MS; Teresa Quattrin, MD
Diabetes Care August 2003, Vol.26, 2365-2369. doi:https://doi.org/10.2337/diacare.26.8.2365
Emerging Treatments and Technologies
Effect on Glycemic Control of Exenatide (Synthetic Exendin-4) Additive to Existing Metformin and/or Sulfonylurea Treatment in Patients With Type 2 Diabetes
Mark S. Fineman, BS; Thomas A. Bicsak, PHD; Larry Z. Shen, PHD; Kristin Taylor, PHD; Eling Gaines, BS; Amanda Varns, BA; Dennis Kim, MD; Alain D. Baron, MD
Diabetes Care August 2003, Vol.26, 2370-2377. doi:https://doi.org/10.2337/diacare.26.8.2370
Hyperbaric Oxygenation Accelerates the Healing Rate of Nonischemic Chronic Diabetic Foot Ulcers: A prospective randomized study
Laurence Kessler, MD, PHD; Pascal Bilbault, MD; Francoise Ortéga, MD; Claire Grasso, MD, PHD; Raphael Passemard, MD, PHD; Dominique Stephan, MD, PHD; Michel Pinget, MD, PHD; Francis Schneider, MD, PHD
Diabetes Care August 2003, Vol.26, 2378-2382. doi:https://doi.org/10.2337/diacare.26.8.2378
Pathophysiology/Complications
Plasma Adiponectin and Leptin Levels, Body Composition, and Glucose Utilization in Adult Women With Wide Ranges of Age and Obesity
Alice S. Ryan, PHD; Dora M. Berman, PHD; Barbara J. Nicklas, PHD; Madhur Sinha, PHD; Ronald L. Gingerich, PHD; Grady S. Meneilly, MD; Josephine M. Egan, MD; Dariush Elahi, PHD
Diabetes Care August 2003, Vol.26, 2383-2388. doi:https://doi.org/10.2337/diacare.26.8.2383
Microalbuminuria and Mortality in Long-Duration Type 1 Diabetes
Diabetes Care August 2003, Vol.26, 2389-2391. doi:https://doi.org/10.2337/diacare.26.8.2389
Racial Differences in Diabetic Nephropathy, Cardiovascular Disease, and Mortality in a National Population of Veterans
Diabetes Care August 2003, Vol.26, 2392-2399. doi:https://doi.org/10.2337/diacare.26.8.2392
Optimal Blood Glucose Control During 18 Years Preserves Peripheral Nerve Function in Patients With 30 Years’ Duration of Type 1 Diabetes
Jakob R. Larsen, MD; Hans Sjoholm, MD, PHD; Kristian F. Hanssen, MD, PHD; Leiv Sandvik, PHD; Tore J. Berg, MD, PHD; Knut Dahl-Jorgensen
Diabetes Care August 2003, Vol.26, 2400-2404. doi:https://doi.org/10.2337/diacare.26.8.2400
Physiological Differences Between Interstitial Glucose and Blood Glucose Measured in Human Subjects
Eray Kulcu, MS; Janet A. Tamada, PHD; Gerard Reach, MD; Russell O. Potts, PHD; Matthew J. Lesho, PHD
Diabetes Care August 2003, Vol.26, 2405-2409. doi:https://doi.org/10.2337/diacare.26.8.2405
Phenotypic Heterogeneity and Associations of Two Aldose Reductase Gene Polymorphisms With Nephropathy and Retinopathy in Type 2 Diabetes
Ying Wang, MD, CHB; Maggie C.Y. Ng, BSC, PHD; Shao-Chin Lee, PHD; Wing-Yee So, MBCHB, MRCP; Peter C.Y. Tong, MBCHB, MRCP; Clive S. Cockram, MD, FRCP; Julian A.J.H. Critchley, PHD, FRCP; Juliana C.N. Chan, MD, FRCP
Diabetes Care August 2003, Vol.26, 2410-2415. doi:https://doi.org/10.2337/diacare.26.8.2410
APOE Polymorphism and the Progression of Diabetic Nephropathy in Japanese Subjects With Type 2 Diabetes: Results of a prospective observational follow-up study
Shin-ichi Araki, MD, PHD; Daisuke Koya, MD, PHD; Tetsuya Makiishi, MD; Toshiro Sugimoto, MD, PHD; Motohide Isono, MD, PHD; Ryuichi Kikkawa, MD, PHD; Atsunori Kashiwagi, MD, PHD; Masakazu Haneda, MD, PHD
Diabetes Care August 2003, Vol.26, 2416-2420. doi:https://doi.org/10.2337/diacare.26.8.2416
ACE Inhibitors Improve Diabetic Nephropathy Through Suppression of Renal MCP-1
Diabetes Care August 2003, Vol.26, 2421-2425. doi:https://doi.org/10.2337/diacare.26.8.2421
Quantitative Insulin Sensitivity Check Index and the Reciprocal Index of Homeostasis Model Assessment in Normal Range Weight and Moderately Obese Type 2 Diabetic Patients
Hisayo Yokoyama, MD; Masanori Emoto, MD, PHD; Shigehiko Fujiwara, MD; Koka Motoyama, MD; Tomoaki Morioka, MD; Miyoko Komatsu, MD, PHD; Hideki Tahara, MD, PHD; Tetsuo Shoji, MD, PHD; Yasuhisa Okuno, MD, PHD; Yoshiki Nishizawa, MD, PHD
Diabetes Care August 2003, Vol.26, 2426-2432. doi:https://doi.org/10.2337/diacare.26.8.2426
Reviews/Commentaries/Position Statements
Heart Failure: The frequent, forgotten, and often fatal complication of diabetes
Diabetes Care August 2003, Vol.26, 2433-2441. doi:https://doi.org/10.2337/diacare.26.8.2433
Adiponectin: More Than Just Another Fat Cell Hormone?
Diabetes Care August 2003, Vol.26, 2442-2450. doi:https://doi.org/10.2337/diacare.26.8.2442
Translating Research to Practice: Lessons learned, areas for improvement, and future directions
Diabetes Care August 2003, Vol.26, 2451-2456. doi:https://doi.org/10.2337/diacare.26.8.2451
Diabetes Issues in Women and Children: Polycystic ovary syndrome
Diabetes Care August 2003, Vol.26, 2457-2463. doi:https://doi.org/10.2337/diacare.26.8.2457
Editorials
The Glycemic Index: Not the most effective nutrition therapy intervention
Diabetes Care August 2003, Vol.26, 2466-2468. doi:https://doi.org/10.2337/diacare.26.8.2466
Letters: Observations
Ethnic Differences in β-Cell Functional Reserve and Clinical Features in Patients With Ketosis-Prone Diabetes
Mario R. Maldonado, MD; Max E. Otiniano, MD; Rebekah Lee, PA; Lucille Rodriguez, LVN; Ashok Balasubramanyam, MD
Diabetes Care August 2003, Vol.26, 2469. doi:https://doi.org/10.2337/diacare.26.8.2469
Modulation of Oxidative and Antioxidative Status in Diabetes by Asphaltum Panjabinum
Nidhi Saxena, PHD; Upendra N. Dwivedi, PHD; Raj K. Singh, PHD; Arvind Kumar, MD; Chhavi Saxena, MSC, BAMS; Ram C. Saxena, MD; Mona Saxena, PHD
Diabetes Care August 2003, Vol.26, 2469-2470. doi:https://doi.org/10.2337/diacare.26.8.2469-a
The Use of Complementary and Alternative Medicine Therapies in Type 2 Diabetic Patients in Mexico
Nicolas Argáez-López, MD; Niels H. Wacher, MD, MSC; Jesus Kumate-Rodríguez, MD, PHD; Miguel Cruz, PHD; Juan Talavera, MD, MSC; Erika Rivera-Arce, PHD; Xavier Lozoya, Dr.; For the DIMSS Study Group
Diabetes Care August 2003, Vol.26, 2470-2471. doi:https://doi.org/10.2337/diacare.26.8.2470
Case Study: Metformin-Associated Lactic Acidosis: Could orlistat be relevant?
Diabetes Care August 2003, Vol.26, 2471-2472. doi:https://doi.org/10.2337/diacare.26.8.2471
Subcutaneous Glucagon May Be Better Than Oral Glucose for Prehospital Treatment of Symptomatic Hypoglycemia
Diabetes Care August 2003, Vol.26, 2472-2473. doi:https://doi.org/10.2337/diacare.26.8.2472
Usefulness of Home Blood Pressure Measurement in the Morning in Type 1 Diabetic Patients
Diabetes Care August 2003, Vol.26, 2473-2475. doi:https://doi.org/10.2337/diacare.26.8.2473
Homocysteinemia Is Not Changed by 3-Day Insulin-Induced Normoglycemia in Type 2 Diabetic Subjects
Marie-Christine Beauvieux, PD, PHD; Vincent Rigalleau, MD, PHD; Caroline Perlemoine, MD; Laurence Baillet, MD; Henri Gin, MD, PHD
Diabetes Care August 2003, Vol.26, 2475-2476. doi:https://doi.org/10.2337/diacare.26.8.2475
Telemedicine Improves Eye Examination Rates in Individuals With Diabetes: A model for eye-care delivery in underserved communities
Richard M. Davis, MD; Stanley Fowler, MD; Kim Bellis, MD; Jeffrey Pockl, MD; Vytautas al Pakalnis, MD; Andrew Woldorf, MD
Diabetes Care August 2003, Vol.26, 2476. doi:https://doi.org/10.2337/diacare.26.8.2476
Interactions Between Peroxisome Proliferator–Activated Receptor Gene Polymorphism and Birth Length Influence Risk for Type 2 Diabetes
Johan G. Eriksson, MD, PHD; Clive Osmond, PHD; Virpi Lindi, MSC; Matti Uusitupa, MD, PHD; Tom Forsen, MD, PHD; Markku Laakso, MD, PHD; David Barker, FRC
Diabetes Care August 2003, Vol.26, 2476-2477. doi:https://doi.org/10.2337/diacare.26.8.2476-a
A Novel Serotonin Blocker, Sarpogrelate, Increases Circulating Adiponectin Levels in Diabetic Patients With Arteriosclerosis Obliterans
Jun’ichi Yamakawa, MD; Takashi Takahashi, MD; Tohoru Itoh, MD; Kazuya Kusaka, MD; Ken Kawaura, MD; Xin Qui Wang, MD; Tsugiyasu Kanda, MD
Diabetes Care August 2003, Vol.26, 2477-2478. doi:https://doi.org/10.2337/diacare.26.8.2477
Reduced Level of Opioid Peptides, Hemorphin-7 Peptides, in Serum of Diabetic Patients
Ingrid I. Fruiter-Arnaudin, PHD; Marie M. Cohen, PHD; Solange S. Nervi, PHD; Stephanie S. Bordenave, PHD; Frederic F. Sannier, PHD; Jean-Marie J.M. Piot, PHD
Diabetes Care August 2003, Vol.26, 2480. doi:https://doi.org/10.2337/diacare.26.8.2480
Prolonged Corrected QT Interval Is Associated With Acute and Chronic Hyperinsulinemia in Nondiabetic Subjects
Tomi Laitinen, MD; Ilkka Vauhkonen, MD; Leo Niskanen, MD; Juha Hartikainen, MD; Matti Uusitupa, MD; Markku Laakso, MD
Diabetes Care August 2003, Vol.26, 2480-2481. doi:https://doi.org/10.2337/diacare.26.8.2480-a
Long-Term, Randomized Clinical Trial of Two Diets in the Metabolic Syndrome and Type 2 Diabetes
Lynne W. Scott, MA; Ashok Balasubramanyam, MD; Kay T. Kimball, PHD; Amy K. Aherns, MS; C. Michael Fordis, Jr., MD; Christie M. Ballantyne, MD
Diabetes Care August 2003, Vol.26, 2481-2482. doi:https://doi.org/10.2337/diacare.26.8.2481
Fenofibrate Monotherapy Induced Rhabdomyolysis
Diabetes Care August 2003, Vol.26, 2482-2483. doi:https://doi.org/10.2337/diacare.26.8.2482
Insulin Injection Abscesses Caused by Mycobacterium Chelonae
Katherine Finucane, BMBCH; Phil Ambrey, MRCP; Shalini Narayan, MRCP; Clive B. Archer, MD, PHD; Colin Dayan, FRCP, PHD
Diabetes Care August 2003, Vol.26, 2483-2484. doi:https://doi.org/10.2337/diacare.26.8.2483
Letters: Comments and Responses
Clarification of Statements in 2003 Clinical Practice Recommendations: Response to Rosival
Diabetes Care August 2003, Vol.26, 2484-2485. doi:https://doi.org/10.2337/diacare.26.8.2484-a
Insulin Pump Therapy: a Meta-Analysis: Response to Weissberg-Benchell et al.
Diabetes Care August 2003, Vol.26, 2485. doi:https://doi.org/10.2337/diacare.26.8.2485
Insulin Pump Therapy: a Meta-Analysis: Response to DeVries et al.
Diabetes Care August 2003, Vol.26, 2485-2486. doi:https://doi.org/10.2337/diacare.26.8.2485-a
